Channel: CNBC

Category: News & Politics

Tags: cnbcmedical billsstocksdiabeticnews channelinsulin pumpswhy is healthcare so expensivecablebusiness newsstem cellsmoney tipsnews stationstock markethospital billscable newshealthcare costsworld newswhy are medical bills so expensivefinance stockfinancial newsmoneyfinance newsmedical costsus newsstock market newsdiabetesprescription billsbreaking news

Description: Over the past 20 years, significant advancements in stem cell research and therapies have been one of the most promising methods of creating new insulin making cells needed to cure type 1 diabetes. Vertex Pharmaceuticals, a biotech company, recently began a clinical trial where it plans to treat 17 participants who have type 1 diabetes with new stem cell derived insulin making cells. The first patient in the trial has had positive results. Other companies around the world including ViaCyte and CRISPR, as well as Novo Nordisk, one of the biggest insulin manufacturers in the world, are also working on curing the disease. CNBC explores why finding a cure for diabetes is so hard and just how close Vertex and other companies are to solving this problem. » Subscribe to CNBC: cnb.cx/SubscribeCNBC » Subscribe to CNBC TV: cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC Classic: cnb.cx/SubscribeCNBCclassic About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more. Connect with CNBC News Online Get the latest news: cnbc.com Follow CNBC on LinkedIn: cnb.cx/LinkedInCNBC Follow CNBC News on Facebook: cnb.cx/LikeCNBC Follow CNBC News on Twitter: cnb.cx/FollowCNBC Follow CNBC News on Instagram: cnb.cx/InstagramCNBC #CNBC How There Could Finally Be A Cure For Diabetes